Skip to main content

View full-text article in PMC

. 2020 Jul 7;26(25):3586–3602. doi: 10.3748/wjg.v26.i25.3586

Table 3.

Multivariate analysis of overall survival

Parameter	Category	Hazard ratio	95%CI	P value
Age (yrs)	< 60	0.139	0.907 (0.544–1.514)	0.709
Age (yrs)	≥ 60	0.139	0.907 (0.544–1.514)	0.709
Sex	Male	0.013	1.031 (0.613–1.734)	0.908
Sex	Female	0.013	1.031 (0.613–1.734)	0.908
Histopathological subtypes	High	0.536	1.184 (0.754–1.859)	0.464
	Middle
	Low
TNM stage	1-II	5.692	3.046 (1.220–7.604)	0.017^a
TNM stage	III-IV	5.692	3.046 (1.220–7.604)	0.017^a
Tumor size	< 3 cm	1.297	1.378 (0.794–2.394)	0.255
Tumor size	≥ 3 cm	1.297	1.378 (0.794–2.394)	0.255
Tumor location	Head	3.450	1.487 (0.978–2.261)	0.063
Tumor location	Body/tail	3.450	1.487 (0.978–2.261)	0.063
Lymph node metastasis	Negative	7.855	2.231 (1.273–3.909)	0.005^b
Lymph node metastasis	Positive	7.855	2.231 (1.273–3.909)	0.005^b
TBL1XR1 expression	Low	13.951	3.507 (1.815–6.774)	< 0.001^c
TBL1XR1 expression	High	13.951	3.507 (1.815–6.774)	< 0.001^c

^a

P < 0.05.

^b

P < 0.01.

^c

P < 0.001.TBL1XR1: Transducin (β)-like 1 X-linked receptor 1; CI: Confidence interval; TNM: Tumor-node-metastasis.